NCT07388420

Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-01-02Est. Completion: 2026-12-31

Enrollment target: 40 participants

Locations

Department of Gastroenterology, General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area), Shenyang, Liaoning, China

Contact

Hypertriglyceridemic Acute PancreatitisAcute Pancreatitis, Hypertriglyceridemia-inducedHyperlipidemia

Background: Hypertriglyceridemia-associated acute pancreatitis (HTG-AP) has become the second most common cause of acute…

Xiamen, ChinaEst. completion Jan 18, 2028

Hypertriglyceridemia Induced Acute PancreatitisRecurrent Acute PancreatitisPancreatitis RelapsingHypertriglyceridemia

Hypertriglyceridemia-induced acute pancreatitis (HTG-AP) is associated with a high risk of recurrence despite standard l…

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.